COVID-19 Impact on Spinal Devices and Biologics Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Spinal Devices and Biologics Industry

1.7 COVID-19 Impact: Spinal Devices and Biologics Market Trends

2 Global Spinal Devices and Biologics Quarterly Market Size Analysis

2.1 Spinal Devices and Biologics Business Impact Assessment - COVID-19

2.1.1 Global Spinal Devices and Biologics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Spinal Devices and Biologics Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Spinal Devices and Biologics Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Spinal Devices and Biologics Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Spinal Devices and Biologics Factory Price by Manufacturers

3.3 Location of Key Manufacturers Spinal Devices and Biologics Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Spinal Devices and Biologics Market

3.5 Key Manufacturers Spinal Devices and Biologics Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Spinal Devices and Biologics Segments, By Type

4.1 Introduction

1.4.1 Spinal Fusion & Fixation

1.4.2 Motion Preservation

1.4.3 Non-Fusion Technologies

1.4.4 Fracture Treatment

1.4.5 Other

4.2 By Type, Global Spinal Devices and Biologics Market Size, 2019-2021

4.2.1 By Type, Global Spinal Devices and Biologics Market Size by Type, 2020-2021

4.2.2 By Type, Global Spinal Devices and Biologics Price, 2020-2021

5 Impact of Covid-19 on Spinal Devices and Biologics Segments, By Application

5.1 Overview

5.5.1 Hospitals

5.5.2 Ambulatory Surgical Centers

5.5.3 Clinics

5.5.4 Other

5.2 By Application, Global Spinal Devices and Biologics Market Size, 2019-2021

5.2.1 By Application, Global Spinal Devices and Biologics Market Size by Application, 2019-2021

5.2.2 By Application, Global Spinal Devices and Biologics Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Nuvasive

7.1.1 Nuvasive Business Overview

7.1.2 Nuvasive Spinal Devices and Biologics Quarterly Production and Revenue, 2020

7.1.3 Nuvasive Spinal Devices and Biologics Product Introduction

7.1.4 Nuvasive Response to COVID-19 and Related Developments

7.2 Orthofix International

7.2.1 Orthofix International Business Overview

7.2.2 Orthofix International Spinal Devices and Biologics Quarterly Production and Revenue, 2020

7.2.3 Orthofix International Spinal Devices and Biologics Product Introduction

7.2.4 Orthofix International Response to COVID-19 and Related Developments

7.3 Exactech

7.3.1 Exactech Business Overview

7.3.2 Exactech Spinal Devices and Biologics Quarterly Production and Revenue, 2020

7.3.3 Exactech Spinal Devices and Biologics Product Introduction

7.3.4 Exactech Response to COVID-19 and Related Developments

7.4 Wright Medical Group

7.4.1 Wright Medical Group Business Overview

7.4.2 Wright Medical Group Spinal Devices and Biologics Quarterly Production and Revenue, 2020

7.4.3 Wright Medical Group Spinal Devices and Biologics Product Introduction

7.4.4 Wright Medical Group Response to COVID-19 and Related Developments

7.5 Johnson & Johnson

7.5.1 Johnson & Johnson Business Overview

7.5.2 Johnson & Johnson Spinal Devices and Biologics Quarterly Production and Revenue, 2020

7.5.3 Johnson & Johnson Spinal Devices and Biologics Product Introduction

7.5.4 Johnson & Johnson Response to COVID-19 and Related Developments

7.6 Zimmer Biomet

7.6.1 Zimmer Biomet Business Overview

7.6.2 Zimmer Biomet Spinal Devices and Biologics Quarterly Production and Revenue, 2020

7.6.3 Zimmer Biomet Spinal Devices and Biologics Product Introduction

7.6.4 Zimmer Biomet Response to COVID-19 and Related Developments

7.7 Globus Medical

7.7.1 Globus Medical Business Overview

7.7.2 Globus Medical Spinal Devices and Biologics Quarterly Production and Revenue, 2020

7.7.3 Globus Medical Spinal Devices and Biologics Product Introduction

7.7.4 Globus Medical Response to COVID-19 and Related Developments

7.8 K2M

7.8.1 K2M Business Overview

7.8.2 K2M Spinal Devices and Biologics Quarterly Production and Revenue, 2020

7.8.3 K2M Spinal Devices and Biologics Product Introduction

7.8.4 K2M Response to COVID-19 and Related Developments

7.9 Medtronic

7.9.1 Medtronic Business Overview

7.9.2 Medtronic Spinal Devices and Biologics Quarterly Production and Revenue, 2020

7.9.3 Medtronic Spinal Devices and Biologics Product Introduction

7.9.4 Medtronic Response to COVID-19 and Related Developments

7.10 Alphatec Holdings

7.10.1 Alphatec Holdings Business Overview

7.10.2 Alphatec Holdings Spinal Devices and Biologics Quarterly Production and Revenue, 2020

7.10.3 Alphatec Holdings Spinal Devices and Biologics Product Introduction

7.10.4 Alphatec Holdings Response to COVID-19 and Related Developments

7.11 RTI Surgical

7.11.1 RTI Surgical Business Overview

7.11.2 RTI Surgical Spinal Devices and Biologics Quarterly Production and Revenue, 2020

7.11.3 RTI Surgical Spinal Devices and Biologics Product Introduction

7.11.4 RTI Surgical Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Spinal Devices and Biologics Supply Chain Analysis

8.1.1 Spinal Devices and Biologics Supply Chain Analysis

8.1.2 Covid-19 Impact on Spinal Devices and Biologics Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Spinal Devices and Biologics Distribution Channels

8.2.2 Covid-19 Impact on Spinal Devices and Biologics Distribution Channels

8.2.3 Spinal Devices and Biologics Distributors

8.3 Spinal Devices and Biologics Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Spinal Devices and Biologics Assessment

Table 9. COVID-19 Impact: Spinal Devices and Biologics Market Trends

Table 10. COVID-19 Impact Global Spinal Devices and Biologics Market Size

Table 11. Global Spinal Devices and Biologics Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Spinal Devices and Biologics Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Spinal Devices and Biologics Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Spinal Devices and Biologics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Spinal Devices and Biologics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Spinal Devices and Biologics Market Growth Drivers

Table 17. Global Spinal Devices and Biologics Market Restraints

Table 18. Global Spinal Devices and Biologics Market Opportunities

Table 19. Global Spinal Devices and Biologics Market Challenges

Table 20. Key Manufacturers Spinal Devices and Biologics Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Spinal Devices and Biologics Market Size, 2019 (K Units) & (US$ Million)

Table 22. Spinal Devices and Biologics Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Spinal Devices and Biologics Manufacturing Plants

Table 24. Key Manufacturers Spinal Devices and Biologics Market Served

Table 25. Date of Key Manufacturers Enter into Spinal Devices and Biologics Market

Table 26. Key Manufacturers Spinal Devices and Biologics Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Spinal Devices and Biologics Market Size by Type, 2020, (US$ Million)

Table 29. Global Spinal Devices and Biologics Market Size by Type, 2020 (K Units)

Table 30. Global Spinal Devices and Biologics Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Spinal Devices and Biologics Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Spinal Devices and Biologics Market Size by Application, 2020-2021 (K Units)

Table 33. Global Spinal Devices and Biologics Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Spinal Devices and Biologics Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Spinal Devices and Biologics Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Spinal Devices and Biologics Market Size, 2019-2021 (K Units)

Table 38. US Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Spinal Devices and Biologics Market Size, 2019-2021 (K Units)

Table 43. Germany Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Spinal Devices and Biologics Market Size, 2019-2021 (K Units)

Table 50. China Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Spinal Devices and Biologics Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. Nuvasive Business Overview

Table 58. Nuvasive Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Nuvasive Spinal Devices and Biologics Product

Table 60. Nuvasive Response to COVID-19 and Related Developments

Table 61. Orthofix International Business Overview

Table 62. Orthofix International Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Orthofix International Spinal Devices and Biologics Product

Table 64. Orthofix International Response to COVID-19 and Related Developments

Table 65. Exactech Business Overview

Table 66. Exactech Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Exactech Spinal Devices and Biologics Product

Table 68. Exactech Response to COVID-19 and Related Developments

Table 69. Wright Medical Group Business Overview

Table 70. Wright Medical Group Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Wright Medical Group Spinal Devices and Biologics Product

Table 72. Wright Medical Group Response to COVID-19 and Related Developments

Table 73. Johnson & Johnson Business Overview

Table 74. Johnson & Johnson Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Johnson & Johnson Spinal Devices and Biologics Product

Table 76. Johnson & Johnson Response to COVID-19 and Related Developments

Table 77. Zimmer Biomet Business Overview

Table 78. Zimmer Biomet Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Zimmer Biomet Spinal Devices and Biologics Product

Table 80. Zimmer Biomet Response to COVID-19 and Related Developments

Table 81. Globus Medical Business Overview

Table 82. Globus Medical Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Globus Medical Spinal Devices and Biologics Product

Table 84. Globus Medical Response to COVID-19 and Related Developments

Table 85. K2M Business Overview

Table 86. K2M Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. K2M Spinal Devices and Biologics Product

Table 88. K2M Response to COVID-19 and Related Developments

Table 89. Medtronic Business Overview

Table 90. Medtronic Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Medtronic Spinal Devices and Biologics Product

Table 92. Medtronic Response to COVID-19 and Related Developments

Table 93. Alphatec Holdings Business Overview

Table 94. Alphatec Holdings Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Alphatec Holdings Spinal Devices and Biologics Product

Table 96. Alphatec Holdings Response to COVID-19 and Related Developments

Table 97. RTI Surgical Business Overview

Table 98. RTI Surgical Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. RTI Surgical Spinal Devices and Biologics Product

Table 100. RTI Surgical Response to COVID-19 and Related Developments

Table 101. Spinal Devices and Biologics Distributors List

Table 102. Spinal Devices and Biologics Customers List

Table 103. Covid-19 Impact on Spinal Devices and Biologics Customers

List of Figures

Figure 1. Spinal Devices and Biologics Product Picture

Figure 2. Spinal Devices and Biologics Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Spinal Devices and Biologics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Spinal Devices and Biologics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Spinal Devices and Biologics Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Spinal Devices and Biologics Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Spinal Devices and Biologics Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Spinal Devices and Biologics Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Spinal Devices and Biologics Market Size Market Share, 2019-2021